Literature DB >> 72811

The effect of hydrocortisone on the serum creatine kinase activity of muscles diseases.

K Cxyzewski.   

Abstract

Intravenous administration of a single dose of hydrocortisone to patients with the Duchenne type of progressive muscular dystrophy, carriers of Duchenne dystrophy gene caused a short-lasting rise of the serum creatine kinase activity. Administration of hydrocortisone also raised the serum CPK activity in some carriers with a primarly normal CPK level. This phenomenon was observed, though to a lower degree, in limb-girdle muscular dystrophy. The serum CPK activity was sometimes increased after hydrocortisone administration in patients with polymyositis and Kugelberg-Welander spinal muscular atrophy. This phenomenon was never observed in the control group or in cases of myotonic dystrophy. The mechanism of this effect of hydrocortisone on the CPK level is still unknown.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72811     DOI: 10.1007/BF00314052

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

1.  Creatine phosphokinase after submaximal physical exercise in untrained individuals.

Authors:  G Forssell; R Nordlander; O Nyquist; E Orinius; I Styrelius
Journal:  Acta Med Scand       Date:  1975-06

2.  Response of serum creatine phosphokinase to steroid hormone.

Authors:  K Takahashi; M Oimomi; T Shinko; K Shutta; B Matsuo
Journal:  Arch Neurol       Date:  1975-02

3.  The detection of carriers of benign (Becker-type) X-linked muscular dystrophy.

Authors:  R Skinner; A E Emery; A J Anderson; C Foxall
Journal:  J Med Genet       Date:  1975-06       Impact factor: 6.318

4.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

5.  Serum enzyme values following intramuscular administration of lidocaine.

Authors:  J C Zener; D C Harrison
Journal:  Arch Intern Med       Date:  1974-07

6.  Studies of healthy relatives of patients with Duchenne muscular dystrophy.

Authors:  I Hausmanowa-Petrusewicz; J Prot; I Niebrój-Dobosz; L Hetnarska; B Emeryk; B Wasowicz; W Askanas; C Slucka
Journal:  J Neurol Sci       Date:  1968 Nov-Dec       Impact factor: 3.181

7.  Further studies concerning the detection of carriership in the Duchenne type of dystrophy.

Authors:  I Hausmanowa-Petrusewicz; J Prot; I Dobosz; B Emeryk; K Rowińska; K Rubach; A Kopeć; J Kopeć
Journal:  Eur Neurol       Date:  1971       Impact factor: 1.710

8.  Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber.

Authors:  B Mokri; A G Engel
Journal:  Neurology       Date:  1975-12       Impact factor: 9.910

9.  Effect of fasting, phenobarbital, or hydrocortisone on serum creatine-phosphokinase and aldolase activity in myopathic Syrian hamsters.

Authors:  B Solymoss; G Jasmin
Journal:  Proc Soc Exp Biol Med       Date:  1975-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.